The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising advance. Unlike subcutaneous injections, this method offers a less invasive way to deliver GLP-1 https://laytnfmvv066021.get-blogging.com/41414202/glp-1-patches-a-novel-approach-to-glucose-management